10-K/A: Mobix Labs Amends 10-K for Governance, Executive Pay Details
Annual Report Amendment
Mobix Labs, Inc. filed an amendment to its annual report to include previously omitted information on directors, executive compensation, and related party transactions for the fiscal year ended September 30, 2025.
Summary
- This is Amendment No. 1 to the Annual Report on Form 10-K for the fiscal year ended September 30, 2025, filed to include information required by Part III.
- The omitted information pertains to Directors, Executive Officers and Corporate Governance, Executive Compensation, Security Ownership of Certain Beneficial Owners and Management, Certain Relationships and Related Transactions, and Principal Accounting Fees and Services.
- The original omission was in reliance on General Instruction G(3) to Form 10-K, which permits incorporation by reference to a definitive proxy statement filed within 120 days after the fiscal year end.
- The company's Principal Executive Officer and Principal Financial Officer provided Rule 13a-14(a) certifications, with paragraphs 3, 4, and 5 omitted as no financial statements are included in this amendment.
- The aggregate market value of the company's common stock held by non-affiliates was approximately $30.5 million as of March 31, 2025.
- As of November 30, 2025, there were 64,308,034 shares of Class A Common Stock and 2,004,901 shares of Class B Common Stock outstanding.
Sentiment
Score: 3
Explanation: The filing is an administrative amendment, but the underlying details reveal significant executive compensation, particularly in stock awards, against a backdrop of a substantial decline in stock value since the merger. The ongoing need for loans, some personally guaranteed by executives, suggests financial pressures. While corporate governance structures are in place, the financial context raises concerns.
Positives
- The company has a clearly defined corporate governance structure, including a classified Board of Directors and three standing committees: audit, compensation, and nominating.
- The Board has determined that a majority of its non-employee directors are independent under Nasdaq listing standards, enhancing oversight.
- The roles of Chief Executive Officer and Chairman of the Board are separated, which the Board believes allows the CEO to focus on day-to-day operations while the Chairman leads Board oversight.
- A code of business conduct and ethics and an insider trading policy are in place, applicable to all executive officers, directors, and employees.
- The company has a policy against granting new equity awards within four business days before or one business day after the release of material nonpublic information.
Negatives
- The value received at issuance of Post-Closing RSUs for co-founders Battaglia and Samini on April 15, 2025, was approximately $283,333, based on an issuance date stock price of $0.85, significantly lower than the $10.47 stock price used for the aggregate grant date fair value calculation on December 21, 2023, indicating a substantial decline in stock value.
- Fabian Battaglia's total compensation for fiscal year 2025 was $5,527,656, largely driven by stock awards, despite his retirement as CEO and director in July 2025.
- Keyvan Samini's total compensation for fiscal year 2025 was $5,650,112, also largely due to stock awards.
- The company has taken on multiple loans, including a $200,000 loan in December 2024 and a $600,000 Maxim loan in August 2025, with executive officers personally guaranteeing the latter two, suggesting ongoing financing needs and potential financial strain.
- Some executive equity awards have vesting conditions tied to specific Class A Common Stock closing prices ($2.00, $3.00, $3.50, $4.00), which could incentivize short-term price focus.
Risks
- Indemnification agreements for directors and officers may discourage stockholders from initiating lawsuits for breaches of fiduciary duty.
- These indemnification provisions may reduce the likelihood of derivative litigation, potentially benefiting directors and officers even if such actions could benefit the company and its stockholders.
- Stockholders' investments may be adversely affected if the company is required to pay settlement and damage awards against directors and officers under these indemnification provisions.
- The SEC considers indemnification for liabilities arising under the Securities Act to be against public policy and therefore unenforceable.
- The vesting conditions for certain executive equity awards, tied to specific stock price targets, could create incentives that are not fully aligned with long-term shareholder value.
Future Outlook
The filing primarily provides historical corporate governance and compensation details and does not contain explicit forward-looking statements or guidance regarding future financial performance or strategic direction, beyond the vesting schedules of equity awards and maturity dates of loans.
Management Comments
- Philip Sansone, Chief Executive Officer, certified that the report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
- Keyvan Samini, President and Chief Financial Officer, certified that the report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
Industry Context
This amendment provides standard corporate governance and executive compensation disclosures typical for a publicly traded company in the semiconductor industry. The significant equity grants and the decline in stock price from the merger closing date to the RSU issuance date highlight potential challenges in valuation and shareholder alignment common in volatile technology sectors, especially for emerging growth companies.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer and Director | Fabian Battaglia | Philip Sansone | July 2025 | Fabian Battaglia retired |
| Director (Class III) | Dr. Jiong Ma | Michael Long | January 22, 2024 | Dr. Ma resigned |
| Director (Class I) | Fabrizio Battaglia | Philip Sansone | July 25, 2025 | Fabrizio Battaglia stepped down |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Structure | The Board is divided into three classes with staggered three-year terms, ensuring only one class of directors is elected each year. Any changes in director numbers are distributed to maintain equal class sizes. | N/A | Ensures continuity and stability of the board, potentially making hostile takeovers more difficult. |
| Director Elections | Fabrizio Battaglia, Kurt Busch, and William Carpou were elected Class I directors on March 3, 2025, with terms expiring in 2028. David Aldrich, Frederick Goerner, and Keyvan Samini were elected Class II directors on December 18, 2023, with terms expiring in 2026. Dr. Jiong Ma and James Peterson were elected Class III directors on December 18, 2023, with terms expiring in 2027. | March 3, 2025; December 18, 2023 | Updates the composition and term structure of the board, reflecting recent elections and appointments. |
| Director Independence | The Board determined that Messrs. Aldrich, Busch, Carpou, Goerner, and Long are independent as defined under Nasdaq listing standards. | N/A | Ensures compliance with regulatory requirements and promotes objective decision-making by a majority of independent directors. |
| Board Committees | The Board has three standing committees: Audit, Compensation, and Nominating, each operating under an adopted charter available on the investor relations website. Members serve until resignation or Board determination. | N/A | Establishes specialized oversight functions for critical areas such as financial reporting, executive compensation, and board composition, enhancing governance effectiveness. |
| Board Leadership Structure | The positions of Chairman of the Board (James Peterson) and Chief Executive Officer (Philip Sansone) are separated, allowing the CEO to focus on day-to-day business and the Chairman to lead Board advice and oversight. | N/A | Promotes a balance of power and independent oversight, potentially reducing conflicts of interest and improving accountability. |
| Risk Oversight Process | The Board, either as a whole or through its committees, regularly discusses major risk exposures with management, including operational, financial, legal, regulatory, cybersecurity, strategic, and reputational risks. | N/A | Formalizes the board's role in identifying, managing, and mitigating company risks, contributing to overall enterprise risk management. |
| Related Party Transactions Policy | The Board adopted a written policy requiring related party transactions exceeding $120,000 to be reviewed and, if appropriate, approved by the Audit Committee, with certain exceptions. | N/A | Minimizes potential conflicts of interest arising from dealings with affiliates and ensures transparency and proper disclosure. |
| Insider Trading Policy | The company has an insider trading policy and procedures governing the purchase, sale, and other dispositions of its securities by directors, officers, and employees, designed to promote compliance with insider trading laws and Nasdaq standards. | N/A | Aims to prevent illegal insider trading, maintain market integrity, and protect the company's reputation. |
| Equity Award Grant Policy | The company does not grant new awards of stock options, stock appreciation rights, or similar option-like instruments within four business days before or one business day after the release of a Form 10-Q, 10-K, or 8-K that discloses material nonpublic information. | N/A | Aims to prevent the appearance or reality of granting awards based on undisclosed material information, enhancing fairness and transparency. |
Related Party Transactions
- Keyvan Samini (President, CFO, General Counsel, Director) personally guaranteed a $150,000 loan to Legacy Mobix (repaid November 2024) and a $200,000 loan to a subsidiary (matures June 2026).
- Philip Sansone (CEO, Director) and Keyvan Samini (President, CFO, General Counsel, Director) personally guaranteed a $600,000 Maxim loan to Mobix Labs on August 15, 2025.
- Michael Long (director) purchased 300,000 shares of Class A Common Stock for $3,000,000 in a private placement on December 19, 2023, and received 128,570 Make-Whole Shares on November 4, 2024.
- Giuseppe Battaglia (related party) was issued a $330,000 promissory note at 16% interest during the year ended September 30, 2024, which was repaid in April 2025.
- Sage Hill Investors, LLC (beneficial owner of more than 5%) purchased 1,500,000 shares for $15,000,000 on December 18, 2023, received 642,857 Make-Whole Shares on November 4, 2024, and exercised a warrant for 1,500,000 shares on February 25, 2025.
- Chavant Capital Partners (Sponsor) purchased 199,737 shares for $1,997,370 on December 19, 2023, and received 12,944 Make-Whole Shares on November 4, 2024.
- Haley Castro Battaglia (daughter-in-law of former CEO Fabian Battaglia) is employed as a Sales and Marketing Representative with an annual salary of $135,000 and received 55,900 restricted stock units (fair value $100,123) and 25,000 restricted stock units (fair value $30,000).
Stakeholder Impact
- Shareholders are impacted by the significant decline in stock value implied by the RSU issuance price ($0.85) compared to the merger closing price ($10.47), as well as potential dilution from substantial equity awards and warrants.
- Executive officers and directors benefit from significant compensation packages, particularly equity awards, and are protected by indemnification agreements.
- Creditors providing loans to the company may have reduced risk due to personal guarantees from executive officers, but this increases the personal financial risk for the guarantors.
- Employees, including related parties, receive standard benefits and some are granted equity awards, aligning their interests with company performance.
Next Steps
- Finalize compensation arrangements for Philip Sansone as Chief Executive Officer.
- Various restricted stock units and options for executives and directors will continue to vest according to their schedules.
- Annual meetings of stockholders will be held for director elections, with Class II directors' terms expiring in 2026, Class III directors' terms expiring in 2027, and Class I directors' terms expiring in 2028.
Key Dates
| Date | Description |
|---|---|
| September 2020 | Keyvan Samini appointed Chief Financial Officer. |
| February 1, 2021 | Board of Directors Agreement with James Peterson and Frederick Goerner. |
| February 2021 | James Peterson, Frederick Goerner, David Aldrich, and Kurt Busch joined the Board. |
| March 2, 2021 | Board of Directors Agreement with David Aldrich. |
| March 12, 2021 | Board of Directors Agreement with Kurt Busch and William Carpou. |
| June 2021 | William Carpou became a Board member. |
| July 19, 2021 | Warrant Agreement between Chavant and Continental Stock Transfer & Trust Company. Letter Agreement among Chavant, its executive officers, directors, Roth Capital Partners, LLC, Craig-Hallum Capital Group LLC and Chavant Capital Partners LLC. |
| September 2021 | Philip Sansone served as Vice President of Worldwide Sales. |
| May 2022 | James Aralis appointed Chief Technology Officer. |
| August 2022 | Keyvan Samini appointed President and General Counsel. |
| November 15, 2022 | Business Combination Agreement between Chavant, Merger Sub and Mobix Labs, Inc. Keyvan Samini's Employment Term Sheet effective. Fabian Battaglia served as Chief Executive Officer. |
| April 7, 2023 | Amendment No. 1 to the Business Combination Agreement. |
| March 26, 2023 | RSUs granted on May 5, 2022, were cancelled. First Amendment to Board of Directors Agreement with James Peterson and Frederick Goerner. |
| October 19, 2023 | Legacy Mobix borrowed $150,000 from an unrelated finance company. |
| November 13, 2023 | Proxy statement/prospectus filed as part of Registration Statement on Form S-4. |
| November 26, 2023 | Amendment No. 2 to the Business Combination Agreement. |
| November 28, 2023 | Amendment No. 1 to the Agreement and Plan of Merger. |
| December 14, 2023 | Warrant to Purchase Shares of Common Stock between Mobix Labs, Inc. and Sage Hill Investors, LLC. |
| December 18, 2023 | David Aldrich, Frederick Goerner, and Keyvan Samini elected Class II directors (term expiring 2026). Dr. Jiong Ma and James Peterson elected Class III directors (term expiring 2027). Subscription agreement with Sage Hill Investors, LLC. |
| December 19, 2023 | Subscription agreement with Michael Long. Subscription agreement with Chavant Capital Partners (Sponsor PIPE). |
| December 20, 2023 | Warrant to Purchase Shares of Common Stock between Mobix Labs, Inc. and Chavant Capital Partners LLC. Sponsor Letter Agreement. Non-Redemption Agreement and Non-Redemption Warrant. |
| December 21, 2023 | Closing of the Merger with Chavant Capital Acquisition Corp. Amended and Restated Registration Rights and Lock-Up Agreement. Amendment to the Warrant Agreement. |
| January 3, 2025 | Stockholder approval obtained for certain executive and director RSU grants. Stockholders approved the exercise of the Sage Hill Warrant. |
| January 22, 2024 | Dr. Jiong Ma resigned from the Board. Michael Long appointed Class III director. Compensation Committee approved restricted stock awards for co-founders. Board approved non-employee director compensation. |
| February 12, 2024 | Amendment No. 3 to the Business Combination Agreement. |
| February 25, 2025 | Sage Hill Warrant was exercised. |
| March 3, 2025 | Fabrizio Battaglia, Kurt Busch, and William Carpou elected Class I directors with a term expiring at the 2028 annual meeting of stockholders. |
| March 18, 2024 | Common Stock Purchase Agreement and Registration Rights Agreement with B. Riley Principal Capital II, LLC. |
| April 2025 | The $330,000 promissory note to Giuseppe Battaglia was repaid in full. |
| April 4, 2025 | Form of Placement Agency Agreement and Securities Purchase Agreement. |
| April 10, 2025 | Mr. Sansone forfeited options to purchase 172,184 shares and was granted 400,000 RSUs. RSU Award Agreements with David Aldrich, Kurt Busch, William Carpou. |
| April 11, 2025 | Amended and Restated Restricted Stock Unit Award Agreements with James Peterson and Frederick Goerner. |
| April 15, 2025 | Mr. Sansone granted 600,000 RSUs. Post-Closing RSUs granted to co-founders Messrs. Battaglia and Samini. |
| May 5, 2025 | Amended and Restated Restricted Stock Award Agreements with Fabian Battaglia and Keyvan Samini. |
| May 8, 2024 | Business Combination Agreement with RaGE Systems, Inc. |
| July 2025 | Philip Sansone appointed Chief Executive Officer and Director. |
| July 9, 2025 | Mr. Aralis granted 100,000 RSUs. Haley Castro Battaglia granted 25,000 restricted stock units. |
| July 22, 2024 | Form of Securities Purchase Agreement and Registration Rights Agreement. |
| July 24, 2024 | Form of Lock-Up Agreement. |
| July 25, 2025 | Fabrizio Battaglia stepped down from his role as Director. Fabian Battaglia retired as Chief Executive Officer and as a member of the Board. |
| August 13, 2025 | Senior Secured Promissory Note and Securities Purchase Agreement with Lendspark Corporation. Business Loan and Security Agreement and Stock Pledge Agreement with Maximcash Solutions LLC. |
| August 15, 2025 | Philip Sansone and Keyvan Samini personally guaranteed the Maxim loan. Stock Purchase Agreement with Charles William Jacobson. |
| August 20, 2025 | 50,000 of Mr. Aralis's RSUs vested. |
| August 30, 2024 | Condition for Sage Hill Make-Whole Shares was satisfied. |
| September 2, 2025 | Side Letter with Maximcash Solutions LLC. |
| September 19, 2025 | Mr. Sansone granted 1,000,000 RSUs. |
| September 30, 2025 | Fiscal year ended. The closing price of Class A Common Stock on Nasdaq was $0.8061. |
| October 14, 2025 | Registrant's Amendment No. 1 to Registration Statement on Form S-1 filed. |
| October 24, 2025 | Amendments to certain outstanding warrants held by Armistice Capital, LLC. |
| October 30, 2025 | Forms of Amended and Restated Series A, Series B, Common, and Inducement Warrants. |
| November 4, 2024 | Mr. Long received 128,570 Make-Whole Shares. Sage Hill received 642,857 Make-Whole Shares. Sponsor received 12,944 Make-Whole Shares. |
| November 14, 2025 | Schedule 13G filed by Armistice Capital, LLC. |
| November 20, 2025 | Remaining 50,000 of Mr. Aralis's RSUs vested. |
| November 30, 2025 | Number of outstanding shares of Class A and Class B Common Stock reported. |
| December 2, 2024 | A subsidiary of Mobix borrowed $200,000 from an unrelated finance company. |
| December 21, 2025 | Post-Closing RSUs for Messrs. Battaglia and Samini vested in their entirety. |
| January 1, 2026 | Remaining ten percent of Sansone RSUs fully vested. |
| January 7, 2026 | Form of Placement Agency Agreement, Purchase Agreement, and Lock-Up Agreement. |
| January 13, 2026 | Original Form 10-K filed. Determination Date for beneficial ownership calculations. |
| January 28, 2026 | Filing date of this Form 10-K/A. |
Recommendation
sellThe filing reveals a significant disparity between the grant date fair value of executive stock awards and the actual value at issuance, indicating a substantial decline in the company's stock price since the merger. This, combined with the company's apparent ongoing need for external financing, including loans personally guaranteed by executives, suggests underlying financial weakness. While corporate governance structures are in place, the high executive compensation relative to the company's performance and valuation decline, along with the potential for further dilution from outstanding warrants and future equity grants, presents a concerning picture for investors. The stock price performance-based vesting conditions for some executive awards could also be a red flag. A seasoned investor would likely view these factors as indicative of significant risk and poor shareholder value creation, leading to a 'sell' recommendation.
Keywords
MOBIX LABS, MOBX, 10-K/A, SEC Filing, Corporate Governance, Executive Compensation, Director Compensation, Related Party Transactions, Semiconductor Industry, Risk Management, Stock Awards, Restricted Stock Units, Warrants, Nasdaq Capital Market
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.